Loss of Function of the Cytoplasmic Fe-S Assembly Protein CIAO1 Causes a Neuromuscular Disorder with Compromise of Nucleocytoplasmic Fe-S Enzymes.
Nunziata MaioRotem OrbachIrina ZaharievaAna TöpfSandra DonkervoortPinki MunotJuliane MuellerTracey WillisSumit VermaStojan PericDeepa KrishnakumarSniya SudhakarAileen Reghan FoleySarah SilversteinGanka DouglasLynn PaisStephanie DiTroiaChristopher GrunseichYing HuCaroline SewryAnna SarkozyVolker StraubFrancesco MuntoniTracey RouaultCarsten Gerhart BönnemannPublished in: medRxiv : the preprint server for health sciences (2023)
Cytoplasmic and nuclear iron-sulfur enzymes that are essential for genome maintenance and replication depend on the cytoplasmic iron-sulfur assembly (CIA) machinery for cluster acquisition. Here we report that patients with biallelic loss of function in CIAO1 , a key CIA component, develop proximal and axial muscle weakness, fluctuating creatine kinase elevation and respiratory insufficiency. In addition, they present with CNS symptoms including learning difficulties and neurobehavioral comorbidities, along with iron deposition in deep brain nuclei, macrocytic anemia and gastrointestinal symptoms. Mutational analysis and functional assays revealed reduced stability of the variants compared to wild-type CIAO1. Loss of CIAO1 impaired DNA helicases, polymerases and repair enzymes which rely on the CIA complex to acquire their Fe-S cofactors, with lentiviral restoration reversing all patient-derived cellular abnormalities. Our study identifies CIAO1 as a novel human disease gene and provides insights into the broader implications of the iron-sulfur assembly pathway in human health and disease.
Keyphrases
- iron deficiency
- human health
- genome wide
- wild type
- risk assessment
- copy number
- endothelial cells
- chronic kidney disease
- climate change
- metal organic framework
- skeletal muscle
- high throughput
- blood brain barrier
- gene expression
- sleep quality
- small molecule
- protein kinase
- induced pluripotent stem cells
- resting state
- tyrosine kinase
- gene therapy
- transcription factor
- brain injury
- pluripotent stem cells
- circulating tumor cells
- cerebral ischemia